|
1
|
Lee WM, Squires RH, Nyberg SL, Doo E and
Hoofnagle JH: Acute liver failure: Summary of a workshop.
Hepatology. 47:1401–1415. 2008.PubMed/NCBI
|
|
2
|
Marudanayagam R, Shanmugam V, Gunson B, et
al: Aetiology and outcome of acute liver failure. HPB (Oxford).
11:429–434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oketani M, Ido A, Nakayama N, et al:
Etiology and prognosis of fulminant hepatitis and late-onset
hepatic failure in japan: Summary of the annual nationwide survey
between 2004 and 2009. Hepatol Res. 43:97–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han DW: Intestinal endotoxemia as a
pathogenetic mechanism in liver failure. World J Gastroenterol.
8:961–965. 2002.PubMed/NCBI
|
|
5
|
Antoniades CG, Berry PA, Wendon JA and
Vergani D: The importance of immune dysfunction in determining
outcome in acute liver failure. J Hepatol. 49:845–861. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCuskey RS, Urbaschek R, McCuskey PA and
Urbaschek B: In vivo microscopic studies of the responses of the
liver to endotoxin. Klin Wochenschr. 60:749–751. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uhlmann S, Uhlmann D and Spiegel HU:
Evaluation of hepatic microcirculation by in vivo microscopy. J
Invest Surg. 12:179–193. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klintman D, Schramm R, Menger MD and
Thorlacius H: Leukocyte recruitment in hepatic injury:
selectin-mediated leukocyte rolling is a prerequisite for
CD18-dependent firm adhesion. J Hepatol. 36:53–59. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eipel C, Kidess E, Abshagen K, et al:
Antileukoproteinase protects against hepatic inflammation, but not
apoptosis in the response of D-galactosamine-sensitized mice to
lipopolysaccharide. Br J Pharmacol. 151:406–413. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roller J, Laschke MW, Scheuer C and Menger
MD: Heme oxygenase (HO)-1 protects from lipopolysaccharide
(LPS)-mediated liver injury by inhibition of hepatic leukocyte
accumulation and improvement of microvascular perfusion.
Langenbecks Arch Surg. 395:387–394. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ito Y, Bethea NW, Abril ER and McCuskey
RS: Early hepatic microvascular injury in response to acetaminophen
toxicity. Microcirculation. 10:391–400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lawson JA, Fisher MA, Simmons CA, Farhood
A and Jaeschke H: Parenchymal cell apoptosis as a signal for
sinusoidal sequestration and transendothelial migration of
neutrophils in murine models of endotoxin and Fas-antibody-induced
liver injury. Hepatology. 28:761–767. 1998. View Article : Google Scholar
|
|
13
|
Fujiwara K, Ogata I, Ohta Y, et al:
Intravascular coagulation in acute liver failure in rats and its
treatment with antithrombin III. Gut. 29:1103–1108. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamada S, Ogata I, Hirata K, Mochida S,
Tomiya T and Fujiwara K: Intravascular coagulation in the
development of massive hepatic necrosis induced by
Corynebacterium parvum and endotoxin in rats. Scand J
Gastroenterol. 24:293–298. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mochida S, Ohno A, Arai M, Tamatani T,
Miyasaka M and Fujiwara K: Role of adhesion molecules in the
development of massive hepatic necrosis in rats. Hepatology.
23:320–328. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyazaki M, Kato M, Tanaka M, et al:
Antithrombin III injection via the portal vein suppresses liver
damage. World J Gastroenterol. 18:1884–1891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirata K, Ogata I, Ohta Y and Fujiwara K:
Hepatic sinusoidal cell destruction in the development of
intravascular coagulation in acute liver failure of rats. J Pathol.
158:157–165. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding JW, Ning Q, Liu MF, et al: Fulminant
hepatic failure in murine hepatitis virus strain 3 infection:
tissue-specific expression of a novel fgl2 prothrombinase. J Virol.
71:9223–9230. 1997.PubMed/NCBI
|
|
19
|
Mita A, Hashikura Y, Tagawa Y, Nakayama J,
Kawakubo M and Miyagawa S: Expression of Fas ligand by hepatic
macrophages in patients with fulminant hepatic failure. Am J
Gastroenterol. 100:2551–2559. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Streetz K, Leifeld L, Grundmann D, et al:
Tumor necrosis factor α in the pathogenesis of human and murine
fulminant hepatic failure. Gastroenterology. 119:446–460. 2000.
|
|
21
|
Malhi H and Gores GJ: Cellular and
molecular mechanisms of liver injury. Gastroenterology.
134:1641–1654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Touyz RM, Briones AM, Sedeek M, Burger D
and Montezano AC: NOX isoforms and reactive oxygen species in
vascular health. Mol Interv. 11:27–35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen F, Haigh S, Barman S and Fulton DJ:
From form to function: the role of Nox4 in the cardiovascular
system. Front Physiol. 3:4122012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Katsuyama M: NOX/NADPH oxidase, the
superoxide-generating enzyme: its transcriptional regulation and
physiological roles. J Pharmacol Sci. 114:134–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brown DI and Griendling KK: Nox proteins
in signal transduction. Free Radic Biol Med. 47:1239–1253. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arteel GE, Thurman RG, Yates JM and
Raleigh JA: Evidence that hypoxia markers detect oxygen gradients
in liver: pimonidazole and retrograde perfusion of rat liver. Br J
Cancer. 72:889–895. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arteel GE, Iimuro Y, Yin M, Raleigh JA and
Thurman RG: Chronic enteral ethanol treatment causes hypoxia in rat
liver tissue in vivo. Hepatology. 25:920–926. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhong Z, Arteel GE, Connor HD, et al:
Binge drinking disturbs hepatic microcirculation after
transplantation: prevention with free radical scavengers. J
Pharmacol Exp Ther. 290:611–620. 1999.
|
|
29
|
Rosmorduc O, Wendum D, Corpechot C, et al:
Hepatocellular hypoxia-induced vascular endothelial growth factor
expression and angiogenesis in experimental biliary cirrhosis. Am J
Pathol. 155:1065–1073. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bardag-Gorce F, French BA, Li J, et al:
The importance of cycling of blood alcohol levels in the
pathogenesis of experimental alcoholic liver disease in rats.
Gastroenterology. 123:325–335. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Corpechot C, Barbu V, Wendum D, et al:
Hepatocyte growth factor and c-Met inhibition by hepatic cell
hypoxia: a potential mechanism for liver regeneration failure in
experimental cirrhosis. Am J Pathol. 160:613–620. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng X, Luyendyk JP, Zou W, et al:
Neutrophil interaction with the hemostatic system contributes to
liver injury in rats cotreated with lipopolysaccharide and
ranitidine. J Pharmacol Exp Ther. 322:852–861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chaudhuri S, McCullough SS, Hennings L, et
al: Acetaminophen hepatotoxicity and HIF-1α induction in
acetaminophen toxicity in mice occurs without hypoxia. Toxicol Appl
Pharmacol. 252:211–220. 2011.
|
|
34
|
Vollmar B, Wolf B, Siegmund S, Katsen AD
and Menger MD: Lymph vessel expansion and function in the
development of hepatic fibrosis and cirrhosis. Am J Pathol.
151:169–175. 1997.PubMed/NCBI
|
|
35
|
Sun Z, Wang X, Deng X, et al: Beneficial
effects of lexipafant, a PAF antagonist on gut barrier dysfunction
caused by intestinal ischemia and reperfusion in rats. Dig Surg.
17:57–65. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takenaka K, Sakaida I, Yasunaga M and
Okita K: Ultrastructural study of development of hepatic necrosis
induced by TNF-alpha and D-galactosamine. Dig Dis Sci. 43:887–892.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Le Bail B, Bioulac-Sage P, Senuita R,
Quinton A, Saric J and Balabaud C: Fine structure of hepatic
sinusoids and sinusoidal cells in disease. J Electron Microsc Tech.
14:257–282. 1990.PubMed/NCBI
|
|
38
|
Kotoh K, Kato M, Kohjima M, Nakamuta M and
Enjoji M: A new treatment strategy for acute liver failure. World J
Hepatol. 2:395–400. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Levy GA, Liu M, Ding J, et al: Molecular
and functional analysis of the human prothrombinase gene (HFGL2)
and its role in viral hepatitis. Am J Pathol. 156:1217–1225. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Marsden PA, Ning Q, Fung LS, et al: The
Fgl2/fibroleukin prothrombinase contributes to immunologically
mediated thrombosis in experimental and human viral hepatitis. J
Clin Invest. 112:58–66. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bantel H, Lugering A, Heidemann J, et al:
Detection of apoptotic caspase activation in sera from patients
with chronic HCV infection is associated with fibrotic liver
injury. Hepatology. 40:1078–1087. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rutherford AE, Hynan LS, Borges CBS, et
al: Serum apoptosis markers in acute liver failure: a pilot study.
Clin Gastroenterol Hepatol. 5:1477–1483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rutherford A, King LY, Hynan LS, et al:
Development of an accurate index for predicting outcomes of
patients with acute liver failure. Gastroenterology. 143:1237–1243.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Malhi H, Gores GJ and Lemasters JJ:
Apoptosis and necrosis in the liver: A tale of two deaths?
Hepatology. 43(Suppl 1): S31–S44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
De Minicis S, Bataller R and Brenner DA:
NADPH oxidase in the liver: defensive, offensive, or fibrogenic?
Gastroenterology. 131:272–275. 2006.
|
|
46
|
Bedard K and Krause KH: The NOX family of
ROS-generating NADPH oxidases: physiology and pathophysiology.
Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Martyn KD, Frederick LM, von Loehneysen K,
Dinauer MC and Knaus UG: Functional analysis of Nox4 reveals unique
characteristics compared to other NADPH oxidases. Cell Signal.
18:69–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Serrander L, Cartier L, Bedard K, et al:
NOX4 activity is determined by mRNA levels and reveals a unique
pattern of ROS generation. Biochem J. 406:105–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Krause KH: Tissue distribution and
putative physiological function of NOX family NADPH oxidases. Jpn J
Infect Dis. 57:S28–S29. 2004.PubMed/NCBI
|
|
50
|
Meng D, Mei A, Liu J, et al: NADPH oxidase
4 mediates insulin-stimulated HIF-1α and VEGF expression, and
angiogenesis in vitro. PLoS One. 7:e483932012.PubMed/NCBI
|
|
51
|
Hecker L, Vittal R, Jones T, et al: NADPH
oxidase-4 mediates myofibroblast activation and fibrogenic
responses to lung injury. Nat Med. 15:1077–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Barnes JL and Gorin Y: Myofibroblast
differentiation during fibrosis: role of NAD(P)H oxidases. Kidney
Int. 79:944–956. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sedeek M, Callera G, Montezano A, et al:
Critical role of Nox4-based NADPH oxidase in glucose-induced
oxidative stress in the kidney: implications in type 2 diabetic
nephropathy. Am J Physiol Renal Physiol. 299:F1348–F1358. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Reinehr R, Becker S, Eberle A,
Grether-Beck S and Haussinger D: Involvement of NADPH oxidase
isoforms and Src family kinases in CD95-dependent hepatocyte
apoptosis. J Biol Chem. 280:27179–27194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Senturk S, Mumcuoglu M, Gursoy-Yuzugullu
O, Cingoz B, Akcali KC and Ozturk M: Transforming growth
factor-beta induces senescence in hepatocellular carcinoma cells
and inhibits tumor growth. Hepatology. 52:966–974. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Boudreau HE, Emerson SU, Korzeniowska A,
Jendrysik MA and Leto TL: Hepatitis C virus (HCV) proteins induce
NADPH oxidase 4 expression in a transforming growth factor
beta-dependent manner: a new contributor to HCV-induced oxidative
stress. J Virol. 83:12934–12946. 2009. View Article : Google Scholar
|
|
57
|
de Mochel NS, Seronello S, Wang SH, et al:
Hepatocyte NAD(P)H oxidases as an endogenous source of reactive
oxygen species during hepatitis C virus infection. Hepatology.
52:47–59. 2010.PubMed/NCBI
|
|
58
|
Carmona-Cuenca I, Roncero C, Sancho P, et
al: Upregulation of the NADPH oxidase NOX4 by TGF-beta in
hepatocytes is required for its pro-apoptotic activity. J Hepatol.
49:965–976. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Caja L, Sancho P, Bertran E,
Iglesias-Serret D, Gil J and Fabregat I: Overactivation of the
MEK/ERK pathway in liver tumor cells confers resistance to
TGF-{beta}-induced cell death through impairing up-regulation of
the NADPH oxidase NOX4. Cancer Res. 69:7595–7602. 2009.PubMed/NCBI
|
|
60
|
Carmona-Cuenca I, Herrera B, Ventura JJ,
Roncero C, Fernandez M and Fabregat I: EGF blocks NADPH oxidase
activation by TGF-beta in fetal rat hepatocytes, impairing
oxidative stress, and cell death. J Cell Physiol. 207:322–330.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sancho P, Bertran E, Caja L,
Carmona-Cuenca I, Murillo MM and Fabregat I: The inhibition of the
epidermal growth factor (EGF) pathway enhances TGF-beta-induced
apoptosis in rat hepatoma cells through inducing oxidative stress
coincident with a change in the expression pattern of the NADPH
oxidases (NOX) isoforms. Biochim Biophys Acta. 1793:253–263. 2009.
View Article : Google Scholar
|
|
62
|
Sancho P, Mainez J, Crosas-Molist E, et
al: NADPH oxidase NOX4 mediates stellate cell activation and
hepatocyte cell death during liver fibrosis development. PLoS One.
7:e452852012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Diebold I, Petry A, Hess J and Görlach A:
The NADPH oxidase subunit NOX4 is a new target gene of the
hypoxia-inducible factor-1. Mol Biol Cell. 21:2087–2096. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Borbely G, Szabadkai I, Horvath Z, et al:
Small-molecule inhibitors of NADPH oxidase 4. J Med Chem.
53:6758–6762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cifuentes-Pagano E, Csanyi G and Pagano
PJ: NADPH oxidase inhibitors: a decade of discovery from Nox2ds to
HTS. Cell Mol Life Sci. 69:2315–2325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Henriques U: Histological technique in
routine histopathology. An opinion. Pathol Res Pract. 171:417–422.
1981. View Article : Google Scholar : PubMed/NCBI
|
